Acute and Long-term Efficacy of Interleukin-1 Inhibitor Anakinra in Idiopathic and Secondary Pericarditis in Patients Refractory or Intolerant to Conventional Therapy
Citation:
Acute and Long-term Efficacy of Interleukin-1 Inhibitor Anakinra in Idiopathic and Secondary Pericarditis in Patients Refractory or Intolerant to Conventional Therapy. Circulation: Cardiovascular Quality and Outcomes 12 (Suppl_1), A273-A273, 2019. 2019.
In: Circulation: Cardiovascular Quality and Outcomes 12 (Suppl_1), A273-A273, 2019
Published by: MH Saad Shaukat, S Singh, K Davis, M Torosoff, R Peredo-Wende , 2019